News | November 20, 2021
U.S. FDA allows Pfizer and Moderna booster doses for all
This is a shot in the arm for the vaccine manufacturers
This is a shot in the arm for the vaccine manufacturers
Achondroplasia is a genetic condition that causes severely short stature and disproportionate growth
The nutraceutical sector is on the cusp of exponential growth and Covid-19 has accelerated the pace of its applications. Dr R.B Smarta, CMD, Interlink, shares his perspective on the growth opportunities and challenges for the sector
The vaccine will be manufactured and marketed in the Philippines by SII under the brand name Covovax
The system is a compact new addition to the Roche Molecular portfolio, providing efficiency, simplicity and timely results to laboratories of all sizes.
The final data from the trial showed sotrovimab reduces hospitalisation and risk of death by 79% in adults with mild-to-moderate Covid-19 who are at high risk of progression to severe disease
A CRISIL study of 207 pharmaceutical companies that account for 55% of the Rs 3.2 lakh crore-a-year sector revenue indicates as much.
If approved or authorized, Paxlovid would be the first oral antiviral of its kind, to combat SARS-CoV-2
The cream has an estimated market size of US $ 28 million for twelve months ending Jun 2021 according to IQVIA
Launching in 2022, its availability will be expanded to the global market
Subscribe To Our Newsletter & Stay Updated
